The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease
S Poonja, N Rattanathamsakul… - Current opinion in …, 2025 - journals.lww.com
A thorough history and examination, supported by ancillary testing, continues to be the
mainstay of optic neuritis diagnosis. Stratifying typical versus atypical optic neuritis is …
mainstay of optic neuritis diagnosis. Stratifying typical versus atypical optic neuritis is …
The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A …
N Tisavipat, P Jitpratoom, S Siritho… - Multiple Sclerosis and …, 2023 - Elsevier
Background Central nervous system inflammatory demyelinating diseases (CNSIDDs) have
notable interracial heterogeneity. The epidemiology of CNSIDDs in Thailand, a mainland …
notable interracial heterogeneity. The epidemiology of CNSIDDs in Thailand, a mainland …
Familial neuromyelitis optica spectrum disorders: Case series and systematic review
C Wannaphut, T Ongphichetmetha… - Multiple Sclerosis and …, 2023 - Elsevier
Background Neuromyelitis optica spectrum disorders (NMOSD) is considered a complex
multifactorial disorder. Most cases are sporadic, and familial NMOSD is assumed as a rare …
multifactorial disorder. Most cases are sporadic, and familial NMOSD is assumed as a rare …
[HTML][HTML] Use of Complementary and Alternative Medicine in Patients With Idiopathic Inflammatory Demyelinating Diseases of the Central Nervous System: A Cross …
P Kosiyakul, J Jitprapaikulsan… - Current Therapeutic …, 2024 - Elsevier
Background Complementary and alternative medications (CAM) are common among
patients with multiple sclerosis (MS) for physical and psychological support. However, there …
patients with multiple sclerosis (MS) for physical and psychological support. However, there …
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study
DL San Martin, TG Fukuda, TS Nascimento… - Multiple Sclerosis and …, 2024 - Elsevier
Background Relapse rates of 47% have been reported in patients with neuromyelitis optica
(NMOSD) using Azathioprine (AZA) and mycophenolate mofetil (MMF). Prediction of non …
(NMOSD) using Azathioprine (AZA) and mycophenolate mofetil (MMF). Prediction of non …
[HTML][HTML] Sexual and Urinary Dysfunctions Among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Review
N Ebrahimi, K Kazemzadeh, EM Ghaffary… - Rare, 2023 - Elsevier
Background Sexual dysfunctions (SD) and urinary dysfunctions (UD) are noteworthy and
common disorders among patients with neuromyelitis optica spectrum disorder (NMOSD) …
common disorders among patients with neuromyelitis optica spectrum disorder (NMOSD) …
Risk Factors and Outcomes of COVID-19 in Thai Patients with Neuromyelitis Optica Spectrum Disorder: A Single Center Study.
N Sukhonpanich, N Tisavipat, S Siritho… - Journal of the …, 2023 - search.ebscohost.com
Background: Long-term immunotherapy use in patients with neuromyelitis optica spectrum
disorder (NMOSD) raised concerns about the increased risk and severity of infection during …
disorder (NMOSD) raised concerns about the increased risk and severity of infection during …